280 related articles for article (PubMed ID: 27591087)
21. Synthesis of sulfated proteoglycans by bovine glomerular endothelial cells in culture.
Sörensson J; Björnson A; Ohlson M; Ballermann BJ; Haraldsson B
Am J Physiol Renal Physiol; 2003 Feb; 284(2):F373-80. PubMed ID: 12388398
[TBL] [Abstract][Full Text] [Related]
22. Dynamics of absolute amount of nephrin in a single podocyte in puromycin aminonucleoside nephrosis rats calculated by quantitative glomerular proteomics approach with selected reaction monitoring mode.
Kawakami H; Kamiie J; Yasuno K; Kobayashi R; Aihara N; Shirota K
Nephrol Dial Transplant; 2012 Apr; 27(4):1324-30. PubMed ID: 21862459
[TBL] [Abstract][Full Text] [Related]
23. Impact of cyclosporin on podocyte ZO-1 expression in puromycin aminonucleoside nephrosis rats.
Kim BS; Park HC; Kang SW; Choi KH; Ha SK; Han DS; Lee HY
Yonsei Med J; 2005 Feb; 46(1):141-8. PubMed ID: 15744817
[TBL] [Abstract][Full Text] [Related]
24. Ultrastructural study on nephrin expression in experimental puromycin aminonucleoside nephrosis.
Lee YK; Kwon T; Kim DJ; Huh W; Kim YG; Oh HY; Kawachi H
Nephrol Dial Transplant; 2004 Dec; 19(12):2981-6. PubMed ID: 15385636
[TBL] [Abstract][Full Text] [Related]
25. Retinoids as a potential treatment for experimental puromycin-induced nephrosis.
Moreno-Manzano V; Mampaso F; Sepúlveda-Muñoz JC; Alique M; Chen S; Ziyadeh FN; Iglesias-de la Cruz MC; Rodríguez J; Nieto E; Orellana JM; Reyes P; Arribas I; Xu Q; Kitamura M; Lucio Cazana FJ
Br J Pharmacol; 2003 Jun; 139(4):823-31. PubMed ID: 12813006
[TBL] [Abstract][Full Text] [Related]
26. Antifibrotic effect of the Chinese herbs, Astragalus mongholicus and Angelica sinensis, in a rat model of chronic puromycin aminonucleoside nephrosis.
Wang H; Li J; Yu L; Zhao Y; Ding W
Life Sci; 2004 Feb; 74(13):1645-58. PubMed ID: 14738908
[TBL] [Abstract][Full Text] [Related]
27. Effect of aminonucleoside nephrosis on immune complex localization in autologous immune complex nephropathy in rats.
Couser WG; Jermanovich NB; Belok S; Stilmant MM; Hoyer JR
J Clin Invest; 1978 Mar; 61(3):561-72. PubMed ID: 147884
[TBL] [Abstract][Full Text] [Related]
28. Adrenomedullin ameliorates podocyte injury induced by puromycin aminonucleoside in vitro and in vivo through modulation of Rho GTPases.
Dong N; Meng L; Xue R; Yu M; Zhao Z; Liu X
Int Urol Nephrol; 2017 Aug; 49(8):1489-1506. PubMed ID: 28528353
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of glomerular visceral epithelial cell endocytosis during nephrosis induced by puromycin aminonucleoside.
Schwartz MM; Sharon Z; Pauli BU; Lewis EJ
Lab Invest; 1984 Dec; 51(6):690-6. PubMed ID: 6389977
[TBL] [Abstract][Full Text] [Related]
30. In glomerular cells of puromycin aminonucleoside nephrosis rats both phosphorylated and total STAT3 levels increased during proteinuria.
Saygı Hİ; Güngör ZB; Kalay F; Seçkin İ
Acta Histochem; 2018 Aug; 120(6):595-603. PubMed ID: 30054017
[TBL] [Abstract][Full Text] [Related]
31. Renoprotective effect of the L/N-type calcium channel antagonist cilnidipine on puromycin aminonucleoside-induced nephrosis in rats.
Takashima K; Nishiyama C; Arisaka N; Takahashi T; Souma S; Tsuda M; Hayashi M; Kasahara H; Kodama H; Tamura T; Murakami M; Kuroda J; Sato F
Arzneimittelforschung; 2009; 59(2):79-85. PubMed ID: 19338138
[TBL] [Abstract][Full Text] [Related]
32. A study of VEGF and its receptors in two rat models of proteinuria.
Kanellis J; Levidiotis V; Khong T; Cox AJ; Stacker SA; Gilbert RE; Cooper ME; Power DA
Nephron Physiol; 2004; 96(1):P26-36. PubMed ID: 14752241
[TBL] [Abstract][Full Text] [Related]
33. Semi-automated quantitative image analysis of podocyte desmin immunoreactivity as a sensitive marker for acute glomerular damage in the rat puromycin aminonucleoside nephrosis (PAN) model.
Herrmann A; Tozzo E; Funk J
Exp Toxicol Pathol; 2012 Jan; 64(1-2):45-9. PubMed ID: 20591637
[TBL] [Abstract][Full Text] [Related]
34. Temocapril, a long-acting non-SH group angiotensin converting enzyme inhibitor, modulates glomerular injury in chronic puromycin aminonucleoside nephrosis.
Zheng Y; Shirato I; Maeda A; Kobayashi N; Liao J; Shou I; Fukui M; Tomino Y
J Nephrol; 2002; 15(1):36-41. PubMed ID: 11936424
[TBL] [Abstract][Full Text] [Related]
35. Permeability, ultrastructural changes, and distribution of novel proteins in the glomerular barrier in early puromycin aminonucleoside nephrosis.
Dunér F; Lindström K; Hultenby K; Hulkko J; Patrakka J; Tryggvason K; Haraldsson B; Wernerson A; Pettersson E
Nephron Exp Nephrol; 2010; 116(2):e42-52. PubMed ID: 20588063
[TBL] [Abstract][Full Text] [Related]
36. Up-regulation of connexin43 in glomerular podocytes in response to injury.
Yaoita E; Yao J; Yoshida Y; Morioka T; Nameta M; Takata T; Kamiie J; Fujinaka H; Oite T; Yamamoto T
Am J Pathol; 2002 Nov; 161(5):1597-606. PubMed ID: 12414508
[TBL] [Abstract][Full Text] [Related]
37. Key molecular events in puromycin aminonucleoside nephrosis rats.
Guan N; Ding J; Deng J; Zhang J; Yang J
Pathol Int; 2004 Sep; 54(9):703-11. PubMed ID: 15363039
[TBL] [Abstract][Full Text] [Related]
38. Sialic acid supplementation ameliorates puromycin aminonucleoside nephrosis in rats.
Pawluczyk IZ; Najafabadi MG; Brown JR; Bevington A; Topham PS
Lab Invest; 2015 Sep; 95(9):1019-28. PubMed ID: 26121320
[TBL] [Abstract][Full Text] [Related]
39. Anionic site and immunogold quantitation of heparan sulfate proteoglycans in glomerular basement membranes of puromycin aminonucleoside nephrotic rats.
Rada JA; Carlson EC
Anat Rec; 1991 Sep; 231(1):35-47. PubMed ID: 1750710
[TBL] [Abstract][Full Text] [Related]
40. Amelioration of antioxidant enzyme suppression and proteinuria in cyclosporin-treated puromycin nephrosis.
Wang JS; Yang AH; Chen SM; Young TK; Chiang H; Liu HC
Nephron; 1993; 65(3):418-25. PubMed ID: 8289993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
